Epidemiological Study of Hepatitis E Virus in Maintenance Hemodialysis Patients
NCT ID: NCT02645955
Last Updated: 2020-09-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
436 participants
OBSERVATIONAL
2016-05-31
2018-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Evaluate the prevalence and incidence of HEV infection in MHD patients.
2. Compare differences of the prevalence and incidence between the MHD patients and the control. .
Secondary purpose:
Analyze risk factors of HEV infection.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Surveillance of HCV in Uremics and Linking to Medical Care
NCT03803410
Automatic Segmentation Ultrasound-based Radiomics Technology in Diabetic Kidney Disease
NCT05025540
Shear Wave Elastography in Differentiating Acute or Chronic Kidney Disease
NCT04404114
Estimation of Glomerular Filtration Rate (GFR) in Patients With Type 2 Diabetes Mellitus.
NCT01215994
Alternations of Intestinal Microbiota and Health Impact in CKD
NCT03794401
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group, disease history
people who didn't have disease history of Maintenance Hemodialysis
No interventions assigned to this group
The MHD patient group, diseases history
Maintenance Hemodialysis Patients
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Can understand the study progress, willing to sign the informed consent and participate the study
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xiamen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jun Zhang
vice-president of School of public health
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jianjun Niu, M.Sc.
Role: PRINCIPAL_INVESTIGATOR
Zhongshan Hospital Xiamen University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MHD-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.